SS
CNSP icon

SBI Securities’s CNS Pharmaceuticals CNSP Stock Holding History

SBI Securities’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$11 – 4210
2025
Q2 		$11 Hold
1
– – ﹤0.01% 3995
2025
Q1 		$20 Buy
+1
New +$49 ﹤0.01% 3856
2024
Q4 		– Hold
0
– – – 3896

Other funds holding CNSP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

SBI Securities's CNSP Position: Q3 2025 in Review

SBI Securities sold out of CNS Pharmaceuticals (CNSP) in Q3 2025, closing a stake of 1 share — an estimated $11 sold.

SBI Securities first reported a position in CNSP in Q1 2025 and held it in 2 quarters. The position peaked at $20 in Q1 2025. 8 funds tracked by Wall St. Rank hold CNSP as of Q3 2025.

  • SBI Securities reported no remaining CNS Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • SBI Securities sold 1 CNS Pharmaceuticals share in Q3 2025, an estimated $11.
  • SBI Securities first reported a position in CNS Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • SBI Securities's CNS Pharmaceuticals position peaked at $20 in Q1 2025.
  • 8 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.